Although the precise molecular mechanisms that result in a DCM versus an electrophysiological phenotype attributable to an SCN5A variation remain incompletely understood, the SCN5A clinical and experimental evidence for DCM achieved a definitive classification. This evidence concerns the gene SCN5A and familial dilated cardiomyopathy.